INCB-016562

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameINCB-016562
Drug Alias NameINCB-016562INCB-19408INCB-16562
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase JAK1 inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK1
Therapy Area/IndicationsCachexiaMyeloproliferative DisordersHematologic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncyte Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncyte Corp
Active IndicationsN/A
Inactive IndicationsCachexiaMyeloproliferative DisordersHematologic Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A